Your browser doesn't support javascript.
loading
[Progress in the development of treprostinil for the treatment of pulmonary hypertension].
Yang, Q F; Du, M; Li, X Y; He, W J; Su, X; Wang, J; Chen, Y Q.
Afiliación
  • Yang QF; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease/National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou 510120, China.
  • Du M; Gmu-gibh Joint School of Life Sciences, Guangzhou Medical University, Guangzhou 510120, China.
  • Li XY; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease/National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou 510120, China.
  • He WJ; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease/National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou 510120, China.
  • Su X; Nanshan College, Guangzhou Medical University, Guangzhou 510120, China.
  • Wang J; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease/National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou 510120, China.
  • Chen YQ; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease/National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou 510120, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 45(9): 930-935, 2022 Sep 12.
Article en Zh | MEDLINE | ID: mdl-36097931

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipertensión Pulmonar Límite: Humans Idioma: Zh Revista: Zhonghua Jie He He Hu Xi Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipertensión Pulmonar Límite: Humans Idioma: Zh Revista: Zhonghua Jie He He Hu Xi Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China